-
The Brazilian state of Sao Paulo could roll out Sinovac's CoronaVac vaccine against SARS-CoV-2 even without approval from the federal health regulator Anvisa, as reported in NASDAQ.
-
The state's governor Joao Doria made the suggestion amid concern among some critics of President Jair Bolsonaro that the independence of Anvisa is under threat.
-
Doria said Sao Paulo could use the Sinovac vaccine based on approval from health regulators in other countries, adding "there is suspicion that Anvisa could suffer political interference."
-
He added the state would consider the vaccine appropriate for use if approved by authorities "in the US, in Europe and, above all, in Asia."
-
According to the news source, the Brazilian government's principal bet has been on a COVID-19 vaccine being developed by AstraZeneca, though federal health officials have also held talks with other vaccine developers, such as Johnson & Johnson and Pfizer.
To read more NewsPoints articles, click here.
